Keywords: karo, bio, revenues, increase, says, net, sales
Karo Bio revenues increase 16%
Article | 10 February 2000
Karo Bio says that net sales for 1999 increased 16% to 73 millionSwedish kroner ($8.5 million), principally thanks to a milestone payment from Bristol-Myers ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
